Presentation is loading. Please wait.

Presentation is loading. Please wait.

What we know about investments in hepatitis and the need for new advocacy tools Chris Taylor, Associate Director, Viral Hepatitis AIDS 2012 – Global Village.

Similar presentations


Presentation on theme: "What we know about investments in hepatitis and the need for new advocacy tools Chris Taylor, Associate Director, Viral Hepatitis AIDS 2012 – Global Village."— Presentation transcript:

1 What we know about investments in hepatitis and the need for new advocacy tools Chris Taylor, Associate Director, Viral Hepatitis AIDS 2012 – Global Village Session July 23, 2012

2 The Budget Landscape  Very little funding dedicated to viral hepatitis –US – CDC Division of Viral Hepatitis ~$30 million –US – NIH ~$100 million –US – Other agencies – very little to no dedicated funding –WHO – very few staff assigned to viral hepatitis  Need greatly outweighs available funding  Relying on public/private partnerships

3 How You Can Help!  Work with hepatitis advocates in your area  Assist with identifying hepatitis funding while conducting HIV resource tracking  Carry hepatitis advocacy messages  Look at co-infection rates and develop a strategy  Ask like-minded donors to consider hepatitis also  Share your expertise about resource tracking

4  World Hepatitis Alliance –www.worldhepatitisalliance.org  National Viral Hepatitis Roundtable –www.nvhr.org Chris Taylor Associate Director, Viral Hepatitis


Download ppt "What we know about investments in hepatitis and the need for new advocacy tools Chris Taylor, Associate Director, Viral Hepatitis AIDS 2012 – Global Village."

Similar presentations


Ads by Google